Analyst consensus rating
Takeda Pharmaceutical Analyst Rating: Strong Buy
Direct answer
Takeda Pharmaceutical's consensus rating is Strong Buy.
3 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $24.56.
Forecast evidence checked November 18, 2026.
Get free Takeda Pharmaceutical email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $21.64
- Average price target
- $24.56
- High price target
- $26.79
- Low price target
- $20.80
- Low target gap
- -3.9%
- Target upside
- +13.5%
- High target gap
- +23.8%
- Target range width
- 27.7%
- Consensus rating
- Strong Buy
- Analysts
- 3
- Evidence date
- November 18, 2026
- Valid through
- November 25, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Takeda Pharmaceutical?
Takeda Pharmaceutical has a verified Strong Buy consensus. The same dataset has an average price target of $24.56.
How far are Takeda Pharmaceutical's low and high targets from the recorded price?
The low target implies -3.9%, while the high target implies +23.8%.
How many analysts are included in Takeda Pharmaceutical's consensus?
The verified consensus includes 3 analysts.
How is Takeda Pharmaceutical's target upside or downside calculated?
The average target of $24.56 is divided by the recorded price of $21.64, then one is subtracted to produce +13.5%. This does not guarantee a future return.
When was Takeda Pharmaceutical's analyst forecast verified?
The data was verified on 2026-11-18. The dataset is valid through 2026-11-25.